Science.

This is the place to learn all about the science behind our services – from general background about antibodies, to details about our unique technology, to real world problems that our clients have solved.

Latest post:

Anti-Idiotypic Antibodies in Drug Development

On-Demand Webinar

Antibody Discovery in Humans – Starting with Functional, Circulating Antibodies

Fill out the form below to receive a link to the recording.

De Novo Protein Sequencing of Antibodies for Identification of Neutralizing Antibodies in Human Plasma Post SARS-CoV-2 Vaccination

Integrating AI and HDX-MS for Antibody Epitope Mapping

Identifying CDRs by Antibody Sequencing

All posts >>

Applications

Webinars

Monthly webinar series featuring guest speakers and technology deep dives. View on demand.

View on demand

Case studies

Studies, publications, posters and technical notes that used our services and technology to achieve great things.

Literature review

Browse by application area

Find content about your specific industry niche – e.g. antibody discovery, protein engineering, IVD, veterinary medicine, etc.

Applications pages

Rapid Novor Technology

Antibody Affinity Insights with REpAb Antibody Discovery

De Novo Sequencing a Bispecific T Cell Engager

B Cell Sequencing and Polyclonal Sequencing Explained

More about our technology >>

Antibody Learning Center

Anti-Idiotypic Antibodies in Drug Development

Disulfide Bond Engineering

Major Histocompatibility Complex Therapeutic Applications

Visit the learning center >>

Press Releases & News

De Novo Antibody Sequencing Reveals Novel Functional and Neutralizing Antibodies Post-SARS-CoV-2 Vaccination

Rapid Novor Teams Up with PMCC to Evaluate EasyM™ for Multiple Myeloma Minimal Residual Disease Monitoring

Rapid Novor and MAbSilico Partner for World’s First AI-Guided Epitope Mapping Service for Antibodies

More news >>

Upcoming Conferences.

View All Upcoming COnferences

Talk to Our Scientists.

We Have Sequenced 10,000+ Antibodies and We Are Eager to Help You.

Through next generation protein sequencing, Rapid Novor enables reliable discovery and development of novel reagents, diagnostics, and therapeutics. Thanks to our Next Generation Protein Sequencing and antibody discovery services, researchers have furthered thousands of projects, patented antibody therapeutics, and developed the first recombinant polyclonal antibody diagnostics.

Science.

Anti-Idiotypic Antibodies in Drug Development

On-Demand Webinar

Featured Posts

De Novo Protein Sequencing of Antibodies for Identification of Neutralizing Antibodies in Human Plasma Post SARS-CoV-2 Vaccination

Integrating AI and HDX-MS for Antibody Epitope Mapping

Identifying CDRs by Antibody Sequencing

All posts >>

Applications

Webinars

Case studies

Browse by application area

Rapid Novor Technology

Antibody Affinity Insights with REpAb Antibody Discovery

De Novo Sequencing a Bispecific T Cell Engager

B Cell Sequencing and Polyclonal Sequencing Explained

More about our technology >>

Antibody Learning Center

Anti-Idiotypic Antibodies in Drug Development

Disulfide Bond Engineering

Major Histocompatibility Complex Therapeutic Applications

Visit the learning center >>

Press Releases & News

De Novo Antibody Sequencing Reveals Novel Functional and Neutralizing Antibodies Post-SARS-CoV-2 Vaccination

Rapid Novor Teams Up with PMCC to Evaluate EasyM™ for Multiple Myeloma Minimal Residual Disease Monitoring

Rapid Novor and MAbSilico Partner for World’s First AI-Guided Epitope Mapping Service for Antibodies

More news >>

Upcoming Conferences.

Talk to Our Scientists.

We Have Sequenced 10,000+ Antibodies and We Are Eager to Help You.

Services

Science

About

Other programs

Services

Applications

Science

About